CLAIRE BYRD: Open Payments
NPI 1134653116 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 38 payments from 11 companies in 2025. Trend: 2023 $651 · 2024 $788 · 2025 $671
Food & beverage: $602Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $225 |
| Astellas Pharma US Inc | 6 | $171 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Novo Nordisk Inc | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Exact Sciences Corporation | 2 | $33 |
| Becton, Dickinson and Company | 1 | $25 |
| SANOFI PASTEUR INC. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
Products named: VRAYLAR, Veozah, UBRELVY, AIRSUPRA, SHINGRIX, Cologuard Collection Kit, Rybelsus, BD Onclarity.
Industry payments across FL — which companies pay providers there.
